Mileutis raises $20 million to reduce antibiotic use in cows

Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment is the first of its kind in the health and life sciences sector and the first for Mileutis

Click link: Mileutis

Leave a Reply

Your email address will not be published. Required fields are marked *